Inactive Instrument

Cardiovascular Systems, Inc.

Equities

CSII

US1416191062

Medical Equipment, Supplies & Distribution

CARDIOVASCULAR SYSTEMS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

February 09, 2023 at 02:19 pm

Item 2.02. Results of Operations and Financial Condition.

On February 8, 2023, Cardiovascular Systems, Inc. (the "Company") issued a press release regarding the Company's financial results for its second fiscal quarter ended December 31, 2022. A copy of the Company's press release is attached hereto as Exhibit 99.1.




Item 9.01.  Financial Statements and Exhibits.
(d)   Exhibits


Exhibit
Number            Description

       99.1         Press Release dated     F    ebruary     8    , 20    23

--------------------------------------------------------------------------------

Latest news about Cardiovascular Systems, Inc.

Orbusneich Medical Group Holdings Limited and Cardiovascular Systems, Inc. Enters into an Amendment to Distribution Agreement	27/09/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Healthcare Equipment Select Industry Index	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Composite 1500	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 600	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Global BMI Index	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 1000	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P TMI Index	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 600 Health Care	01/05/23	CI
Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from NASDAQ Composite Index	27/04/23	CI
Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. from The Vanguard Group, Inc. and others.	26/04/23	CI
Wall St dips as Treasury yields rise after auction	09/02/23	RE
Wall St dips as Treasury yields rise after auction	09/02/23	RE
Wall St dips as Treasury yields rise; Disney hits 5-month high	09/02/23	RE
Top Midday Gainers	09/02/23	MT
Wall St dips as Alphabet extends fall; Disney hits 5-month high	09/02/23	RE
Sector Update: Health Care Stocks Mixed Premarket Thursday	09/02/23	MT
Top Premarket Gainers	09/02/23	MT
Abbott Laboratories Enters Deal to Acquire Cardiovascular Systems for $890 Million	09/02/23	MT
North American Morning Briefing : Stocks Seen -2-	09/02/23	DJ
North American Morning Briefing : Stocks Seen Bouncing Back, Next Catalysts Eyed	09/02/23	DJ
Cardiovascular Systems Shares Soar Premarket on Abbott Buyout	09/02/23	DJ
Cardiovascular Systems Fiscal Q2 Loss, Revenue Increases; Shares Rise Pre-Bell	09/02/23	MT
EMEA Morning Briefing : Investors to Parse Fed -2-	09/02/23	DJ
Abbott Laboratories to Acquire Cardiovascular Systems At Equity Value of $890 Million	08/02/23	DJ
Cardiovascular Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	08/02/23	CI

Chart Cardiovascular Systems, Inc.

Duration

Period

More charts

Company Profile

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-5.60%	182B
MEDTRONIC PLC	-4.45%	102B
BECTON, DICKINSON AND COMPANY	-4.15%	66.74B
DEXCOM, INC.	-8.63%	45.55B
CENCORA, INC.	+9.70%	44.89B
HOYA CORPORATION	+6.13%	40.62B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	30.04B
TERUMO CORPORATION	+14.80%	24.34B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.95B

Other Medical Equipment, Supplies & Distribution